Britany Helton

Doctor of Public Health (DrPH)

Britany Helton is a Doctor of Public Health Student in the Department of Health Policy and Management.

Britany works full-time with Alpha Omega as a Public Health Analyst with the CDC’s Division of HIV Prevention, focusing on research synthesis and translation. Before Alpha Omega, she was an ORISE fellow for 5 years for the CDC’s Division of High-Consequence Pathogens and Pathologies as an Epidemiologist. Britany has over 10 years of experience in public health and applied research. Her current research interests are injection drug use, syringe service programs, and HIV prevention.

Education

MPH, Georgia State University, 2014, Epidemiology
BA, LaGrange College, 2012, Psychology

More About

Focused on psychometric and instrument creation during the BA degree. During my MPH, I focused on alternative tobacco product research, such as little cigars and hookah.

Areas of Expertise

Injection Drug Use
Syringe Service Programs
HIV Prevention
Research Evaluation, Synthesis, and Translation
Data Management and Quality Control

Honors, Awards, and Achievements

2025 DrPH Day Best Poster Award
University of Georgia Dean Marsha Davis Graduate Scholarship, 2024
DHCPP Spirit Award, 2018
LaGrange College Outstanding Senior in Psychology, 2012
LaGrange College Research Scholar, 2011
Carolyn Huey Harris Lambda Sigma Scholarship, 2012

Research Interests

Injection Drug Use
Syringe Service Programs
HIV Prevention

Selected Publications

1. Unger, E.R.; Lin, J.-M.S.; Chen, Y.; Cornelius, M.E.; Helton, B.; Issa, A.N.; Bertolli, J.; Klimas, N.G.; Balbin, E.G.; Bateman, L.; et al. Heterogeneity in Measures of Illness among Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Is Not Explained by Clinical Practice: A Study in Seven U.S. Specialty Clinics. J. Clin. Med.. 2024, 13, 1369. https://doi.org/10.3390/jcm13051369

2. Querec TD, Lin JS, Chen Y, Helton B, Kogelnik AM, Klimas NG, Peterson DL, Bateman L, Lapp C, Podell RN, Natelson BH, Unger ER; MCAM Study Group. Natural killer cytotoxicity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a multi-site clinical assessment of ME/CFS (MCAM) sub-study. J Transl Med. 2023 Apr 3;21(1):242. doi: 10.1186/s12967-023-03958-2. PMID: 37013608; PMCID: PMC10069115.

3. Unger, E. R., Lin, J. S., Tian, H., Natelson, B. H., Lange, G., Vu, D., Blate, M., Klimas, N. G., Balbin, E. G., Bateman, L., Allen, A., Lapp, C. W., Springs, W., Kogelnik, A. M., Phan, C. C., Danver, J., Podell, R. N., Fitzpatrick, T., Peterson, D. L., Gottschalk, C. G., … MCAM Study Group (2017). Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study. American journal of epidemiology, 185(8), 617–626. https://doi.org/10.1093/aje/kwx029

4. Helton, Britany, “Impact of Internet Usage on Risk Perceptions of Hookah Use.” Thesis, Georgia State University, 2014. doi: https://doi.org/10.57709/5555049